<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Advanced glycation end-products (AGEs) and their receptor (RAGE) occur in <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer's type and diabetic microvascular disease </plain></SENT>
<SENT sid="1" pm="."><plain>Accumulation of AGEs relates to risk factors for vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> with ageing, including <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">Cognitive dysfunction</z:e> in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> may relate to microvascular disease resembling that in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We tested if, among people with cerebrovascular disease, (1) those with <z:hpo ids='HP_0000726'>dementia</z:hpo> have higher levels of neuronal and vascular AGEs and (2) if <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunction</z:e> depends on neuronal and/or vascular AGE levels </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Brain Sections from 25 cases of the OPTIMA (Oxford Project to Investigate Memory and Ageing) cohort, with varying degrees of cerebrovascular pathology and <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunction</z:e> (but only minimal Alzheimer type pathology) were immunostained for Nepsilon-(carboxymethyl)-lysine (<z:mp ids='MP_0005481'>CML</z:mp>), the most abundant AGE </plain></SENT>
<SENT sid="5" pm="."><plain>The level of staining in vessels and neurons in the cortex, white matter and basal ganglia was compared to neuropsychological and other clinical measures </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The probability of cortical neurons staining positive for <z:mp ids='MP_0005481'>CML</z:mp> was higher in cases with worse cognition (p = 0.01) or a history of <z:hpo ids='HP_0000822'>hypertension</z:hpo> (p = 0.028) </plain></SENT>
<SENT sid="7" pm="."><plain>Additionally, vascular <z:mp ids='MP_0005481'>CML</z:mp> staining related to <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (p = 0.02) and a history of <z:mp ids='MP_0002055'>diabetes</z:mp> (p = 0.007) </plain></SENT>
<SENT sid="8" pm="."><plain>Neuronal <z:mp ids='MP_0005481'>CML</z:mp> staining in the basal ganglia related to a history of <z:hpo ids='HP_0000822'>hypertension</z:hpo> (p = 0.002) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:mp ids='MP_0005481'>CML</z:mp> staining in cortical neurons and cerebral vessels is related to the severity of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in people with cerebrovascular disease and only minimal Alzheimer pathology </plain></SENT>
<SENT sid="10" pm="."><plain>These findings support the possibility that cerebral accumulation of AGEs may contribute to <z:hpo ids='HP_0000726'>dementia</z:hpo> in people with cerebrovascular disease </plain></SENT>
</text></document>